The migrastatin family: Discovery of potent cell migration inhibitors by chemical synthesis

被引:157
作者
Gaul, C
Njardarson, JT
Shan, D
Dorn, DC
Wu, KD
Tong, WP
Huang, XY
Moore, MAS
Danishefsky, SJ
机构
[1] Sloan Kettering Inst Canc Res, Bioorgan Chem Lab, New York, NY 10021 USA
[2] Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10021 USA
[3] Sloan Kettering Inst Canc Res, Lab Dev Hematopoiesis, Cell Biol Program, New York, NY 10021 USA
[4] Sloan Kettering Inst Canc Res, Analyt Core Facil, New York, NY 10021 USA
[5] Columbia Univ, Dept Chem, New York, NY 10027 USA
关键词
D O I
10.1021/ja048779q
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The first asymmetric total synthesis of (+)-migrastatin (1), a macrolide natural product with antimetastatic properties, has been accomplished. Our concise and flexible approach utilized a Lewis acid-catalyzed diene aldehyde condensation (LACDAC) to install the three contiguous stereocenters and the trisubstituted (Z)-alkene of migrastatin (2 + 3 --> 21). Construction of the two remaining stereocenters and incorporation of the glutarimide-containing side chain was achieved by an anti-selective aldol addition of propionyl oxazolidinone 28 to angelic aldehyde 27, followed by a Horner-Wadsworth-Emmons (HWE) coupling of 32 with glutarimide aldehyde 5. Finally, the assembly of the macrocycle was realized by a highly (E)-selective ring-closing metathesis (35 --> 37). Utilizing the power of diverted total synthesis (DTS), a series of otherwise inaccessible analogues was prepared and evaluated for their potential as tumor cell migration inhibitors in several in vitro assays. These studies revealed a dramatic increase in activity when the natural motif was considerably simplified, presenting macrolactones 45 and 48, as well as macrolactam 55, macroketone 60, and CF3-alcohol 71 as promising anti-metastatic agents.
引用
收藏
页码:11326 / 11337
页数:12
相关论文
共 110 条
[1]   The anti-selective boron-mediated asymmetric aldol reaction of carboxylic esters [J].
Abiko, A ;
Liu, JF ;
Masamune, S .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (10) :2586-2587
[2]   Stereocontrol in organic synthesis using silicon-containing compounds. A synthesis of methyl (+)-nonactate [J].
Ahmar, M ;
Duyck, C ;
Fleming, I .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1998, (17) :2721-2732
[3]   Azaspirene:: A novel angiogenesis inhibitor containing a 1-oxa-7-azaspiro[4.4]non-2-ene-4,6-dione skeleton produced by the fungus Neosartotya sp. [J].
Asami, Y ;
Kakeya, H ;
Onose, R ;
Yoshida, A ;
Matsuzaki, H ;
Osada, H .
ORGANIC LETTERS, 2002, 4 (17) :2845-2848
[4]   Highly concise routes to epothilones: The total synthesis and evaluation of epothilone 490 [J].
Biswas, K ;
Lin, H ;
Njardarson, JT ;
Chappell, MD ;
Chou, TC ;
Guan, YB ;
Tong, WP ;
He, LF ;
Horwitz, SB ;
Danishefsky, SJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (33) :9825-9832
[5]   HORNER-WADSWORTH-EMMONS REACTION - USE OF LITHIUM-CHLORIDE AND AN AMINE FOR BASE SENSITIVE COMPOUNDS [J].
BLANCHETTE, MA ;
CHOY, W ;
DAVIS, JT ;
ESSENFELD, AP ;
MASAMUNE, S ;
ROUSH, WR ;
SAKAI, T .
TETRAHEDRON LETTERS, 1984, 25 (21) :2183-2186
[6]   PROTON-TRANSFER STEPS IN STEGLICH ESTERIFICATION - A VERY PRACTICAL NEW METHOD FOR MACROLACTONIZATION [J].
BODEN, EP ;
KECK, GE .
JOURNAL OF ORGANIC CHEMISTRY, 1985, 50 (13) :2394-2395
[7]   Tumor angiogenesis - new drugs on the block [J].
Brower, V .
NATURE BIOTECHNOLOGY, 1999, 17 (10) :963-968
[8]   Thalidomide analogues demonstrate dual inhibition of both angiogenesis and prostate cancer [J].
Capitosti, SM ;
Hansen, TP ;
Brown, ML .
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (02) :327-336
[9]   Angiogenesis in health and disease [J].
Carmeliet, P .
NATURE MEDICINE, 2003, 9 (06) :653-660
[10]   Synthesis of (-)-terpestacin via catalytic, stereoselective fragment coupling:: Siccanol is terpestacin, not 11-epi-terpestacin [J].
Chan, J ;
Jamison, TF .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (38) :11514-11515